ATE241366T1 - Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung - Google Patents

Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung

Info

Publication number
ATE241366T1
ATE241366T1 AT93905811T AT93905811T ATE241366T1 AT E241366 T1 ATE241366 T1 AT E241366T1 AT 93905811 T AT93905811 T AT 93905811T AT 93905811 T AT93905811 T AT 93905811T AT E241366 T1 ATE241366 T1 AT E241366T1
Authority
AT
Austria
Prior art keywords
molecular weight
compositions
bimodal molecular
trauma
alkaline earth
Prior art date
Application number
AT93905811T
Other languages
English (en)
Inventor
F Richard Christ
Original Assignee
Advanced Medical Optics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medical Optics Inc filed Critical Advanced Medical Optics Inc
Application granted granted Critical
Publication of ATE241366T1 publication Critical patent/ATE241366T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT93905811T 1992-02-10 1993-02-09 Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung ATE241366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83297292A 1992-02-10 1992-02-10
PCT/US1993/001088 WO1993015744A1 (en) 1992-02-10 1993-02-09 Bimodal molecular weight hyaluronate formulations and methods for using same

Publications (1)

Publication Number Publication Date
ATE241366T1 true ATE241366T1 (de) 2003-06-15

Family

ID=25263080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905811T ATE241366T1 (de) 1992-02-10 1993-02-09 Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung

Country Status (8)

Country Link
EP (1) EP0625904B1 (de)
JP (1) JP3751017B2 (de)
AT (1) ATE241366T1 (de)
AU (1) AU3658793A (de)
CA (1) CA2129238A1 (de)
DE (1) DE69333005T2 (de)
ES (1) ES2199940T3 (de)
WO (1) WO1993015744A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492936A (en) * 1990-11-30 1996-02-20 Allergan, Inc. Bimodal molecular weight hyaluronate formulations and methods for using same
AU2006287485B2 (en) * 2005-09-07 2012-07-12 Amo Regional Holdings Bi-modal hyaluronate solution
MX2008014403A (es) * 2006-05-11 2009-03-23 Sandra Gobbo Mezclas binarias del acido hialuronico y su uso terapeutico.
CA2654255A1 (en) * 2006-06-28 2008-01-03 Novozymes Biopolymer A/S Compositions with several hyaluronic acid fractions for cosmetic and medical uses
WO2008003321A2 (en) * 2006-07-07 2008-01-10 Novozymes Biopolymer A/S Compositions with several hyaluronic acid fractions for cosmetic use
US9539138B2 (en) * 2008-01-30 2017-01-10 Takaya TANAKA Method of ophthalmic surgery and kit therefor
WO2010003797A1 (en) * 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
EP2985019B1 (de) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasale Zusammensetzung mit antiviralen Eigenschaften
EP2985027B1 (de) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasenheilmittel enthaltend ein gemisch von hyaluronsäuren und salzlösung
JP6706632B2 (ja) * 2016-01-05 2020-06-10 デンカ株式会社 半月板変性治療用組成物
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
WO2020117546A1 (en) * 2018-12-03 2020-06-11 Samuel Asculai Pharmaceutical formulations and compositions suitable to treat mucositis
IT201900024208A1 (it) * 2019-12-17 2021-06-17 Altergon Sa Miscele iniettabili di acido ialuronico per uso in dermoestetica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
DE3482812D1 (de) * 1983-10-11 1990-08-30 Fidia Spa Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
CA2129238A1 (en) 1993-08-19
WO1993015744A1 (en) 1993-08-19
JPH07503958A (ja) 1995-04-27
AU3658793A (en) 1993-09-03
DE69333005D1 (de) 2003-07-03
JP3751017B2 (ja) 2006-03-01
EP0625904A1 (de) 1994-11-30
EP0625904B1 (de) 2003-05-28
ES2199940T3 (es) 2004-03-01
DE69333005T2 (de) 2004-04-01

Similar Documents

Publication Publication Date Title
ATE241366T1 (de) Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung
WO1992017159A3 (en) Stabilized emulsion compositions for imparting an artificial tan to human skin
CA2160107A1 (en) Compositions for Imparting an Artificial Tan and Protecting the Skin from UV Radiation
EP0731712A4 (de) Physiologisch stabile butlersäurepräparate, und butlersäuresalze und -derivate als antineoplastische wirkstoff
CA2186500A1 (en) Artificial tanning compositions having improved stability
HUT75089A (en) Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
DE59604165D1 (de) Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DK224184A (da) Parenteralt praeparat af nimodipin, fremgangsmaade til dets fremstilling samt dets anvendelse ved bekaempelse af sygdomme
FR2675997B1 (fr) Composition topique anti radicaux libres a base de superoxyde-dismutase et d'un derive phosphonique.
MX9203667A (es) Sales de bis-dimetoximetil (trimetoxibencil)quinolino, su preparacion y composicines farmaceuticas que las contienen.
DE3160380D1 (en) Substituted 1,2,5-oxadiazole-2-oxides for use as medicaments and medicaments containing them
DE69833937D1 (de) Verwendung von zinkhyaluronat gegen magengeschwür
MX9706957A (es) Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina.
DE59605782D1 (de) Substituierte Benzyloxycarbonylguanidine als Natrium-protonen Antiporter-Inhibitoren, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament
BR9100221A (pt) Composto;metodo para o tratamento de hipertensao,falha cardiaca congestiva ou glaucoma em um mamifero;e composicao farmaceutica
DE69434357D1 (de) Legierung auf Stahlbasis mit hohem Modul und Verfahren zu deren Herstellung
PT87194A (pt) Neue pyrrolidin-2-(1,3-dicarbonyl)-derivate verfahren zu ihrer herstellung sie enthaltende mittel sowie deren verwendung
DE68913822D1 (de) Nichtvernetztes Hydrogel, Verfahren zu seiner Herstellung, seine Verwendung in der Medizin oder Chirurgie, insbesondere als Augenimplantat.
ATA86690A (de) 2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATE86435T1 (de) Antimikrobische zusammensetzung und verfahren zu deren verwendung.
DE69215482D1 (de) 2,2'-Alkylendiindolderivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung als Ulcustherapeutikum
ES2013669A6 (es) Composiciones poliolefinicas para peliculas fotobiodegradables.
SE9201425D0 (sv) Method and means for preventing constriction of the pupil in the eye
NO885640D0 (no) Framgangsmaate og sammensetninger for katodisk beskyttelse.
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties